Although angioplasty or stenting may increase secondary patency in people with acute obstruction due to DVT, the evidence is very uncertain; the evidence is also very uncertain about the effect of ...

The use of drug-eluting stents in clinical practice has altered the treatment perspective for bifurcation lesions; however, relatively high rates of stent thrombosis and restenosis are still observed.

The British Bifurcation Coronary Study randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions was published recently. In the simple strategy, the main vessel was ...

Although true bifurcation lesions are associated with a high risk of procedural complications, the differential prognostic implications of percutaneous coronary intervention for true bifurcations ...

Background Periprocedural antithrombotic treatment is a key determinant for the risk–benefit balance of emergent carotid artery stenting (eCAS) during stroke thrombectomy. We aimed to assess the ...

In this week’s View, Dr. Eagle explores the impact of residual ischemia on cardiovascular mortality in left main bifurcation stenting. He then discusses coronary revascularization guided by ...

Combining these features, the LM V-RESOLVE score demonstrated good accuracy (C-statistic of 0.830) in predicting SB occlusion after LM stenting during unprotected LM PCI. This scoring system can ...

A distal left main stenosis is located at a bifurcation and increases risk for adverse outcomes following PCI, as do lesions in other bifurcations in the coronary tree. Palmerini et al.

They were maintained on aspirin (100 mg/d) plus clopidogrel (75 mg/d) for 90 days after stenting. If the patients had a low activity to aspirin or clopidogrel suggested by the Thromboelastography (TEG ...

More recently, the same technologies have been adapted to permit patient-specific virtual treatment planning. Complex models assessing WSS in bifurcation stenting can provide interesting insights into ...